Outcome predict ability of limited-stage small cell lung cancer after chemoradiation based on early and late metabolic response by 18F-FDG PET/CT
Conclusion In limited-stage SCLC, early tumor complete metabolic response does not indicate good prognosis. Late metabolic response as assessed by 18F-FDG PET/CT is a significantly superior prognostic marker than early metabolic response. the late metabolic response had significantly outcome predict ability.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Li, X., Li, N., Li, Y. Tags: Lung Cancer II: PET-Derived Parameters as Predictors of Response to Therapy Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Lung Cancer | Nuclear Medicine | PET Scan | Small Cell Lung Cancer | Study